Product Information
DAPSONE 7.5% GEL PUMP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.7989 per GM under NDC 62332066390. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Oct 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/g
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332066390
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DAPSONEApproval Type
Generic (ANDA)
FDA Application
ANDA215718FDA Approved
10/27/2023
TE Code
AB
On Market Since
10/30/2023
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 7.5% GEL PUMP has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7989 per GM |
|---|---|
| All-time high | $1.8111 (May 15, 2024) |
| All-time low | $0.7471 (May 20, 2026) |
| 52-week high | $1.2440 |
| 52-week low | $0.7471 |
| Median price | $1.2967 |
| Average price | $1.2273 |
| Largest weekly change | +20.4% (Apr 17, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAPSONE 7.5% GEL PUMP?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 7.5% GEL PUMP, manufactured by Alembic Pharmaceuticals Inc., is $0.7989 per GM (NDC 62332066390), effective Sep 30, 2026.
How has the price of DAPSONE 7.5% GEL PUMP changed over time?
Over the history we have for it, the NADAC for DAPSONE 7.5% GEL PUMP has declined 46.9%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for DAPSONE 7.5% GEL PUMP?
Since Feb 14, 2024, the NADAC for DAPSONE 7.5% GEL PUMP has ranged from a low of $0.7471 (May 20, 2026) to a high of $1.8111 (May 15, 2024), with a median of $1.2967 per GM.
Are there cheaper alternatives to DAPSONE 7.5% GEL PUMP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPSONE 7.5% GEL PUMP, is $0.7152 per GM — about 10% below DAPSONE 7.5% GEL PUMP.
Who manufactures DAPSONE 7.5% GEL PUMP?
DAPSONE 7.5% GEL PUMP (NDC 62332066390) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.